Format
Sort by

Send to:

Choose Destination

Search results

Items: 2

1.

Evidence-based organization and patient safety strategies in European hospitals.

Sunol R, Wagner C, Arah OA, Shaw CD, Kristensen S, Thompson CA, Dersarkissian M, Bartels PD, Pfaff H, Secanell M, Mora N, Vlcek F, Kutaj-Wasikowska H, Kutryba B, Michel P, Groene O; DUQuE Project Consortium.

Int J Qual Health Care. 2014 Apr;26 Suppl 1:47-55. doi: 10.1093/intqhc/mzu016. Epub 2014 Feb 26.

2.

Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.

Mallolas J, Podzamczer D, Milinkovic A, Domingo P, Clotet B, Ribera E, Gutiérrez F, Knobel H, Cosin J, Ferrer E, Arranz JA, Roca V, Vidal F, Murillas J, Pich J, Pedrol E, Llibre JM, Dalmau D, García I, Aranda M, Cruceta A, Martínez E, Blanco JL, Lazzari Ed, Gatell JM; ATAZIP Study Group.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):29-36. doi: 10.1097/QAI.0b013e31819a226f.

PMID:
19390327

Supplemental Content

Loading ...
Write to the Help Desk